Navigation Links
Fat Cell Protein Hits Type-2 Diabetes

According to researchers a protein found in human fat cells may become key to the development of future treatments for type-2 or adult onset diabetes. According to Dr. Lucino Roseveltte, professor of medicine at 0the Hopkins College of Medicine in New York , there are molecules produced by the fat cells, the adipose tissue//, circulating throughout the body and affecting the functions of different organs. Their research identifies one very significant protein, Acpr30, that is made in fat cells--- and made less abundantly in the fat cells of obese people and animals -- that significantly affects insulin action in the liver.

Type-2 diabetes affects between 2 million and 6 million Americans and is rising in epidemic proportions as obesity rates also rise. Type-2 diabetes accounts for 70 percent to 90 percent of all diabetes cases. The majority of people who have type-2 diabetes are obese, about 60 to 80 percent. According to him the idea has been developed that the adipose cell where the fat is stored is also producing very active molecules that are really functioning as hormones. He said his research team found a very clear mechanism by which an increase or decrease in fat cell size, as happens in obese humans, might cause severe hepatic (liver) insulin resistance because less of a hormone-like protein, Acrp30, is secreted by the fat cell.

The researchers used a genetic approach in cells to generate an exact copy of the Acrp30 protein. They injected mice with Acrp30 until they doubled the protein level. The question was that iIf we simply doubled the concentration of this adipose-derived hormone and then carefully measure the hepatic glucose production -- or action of insulin on the liver-- are we generating a significant effect?' The answer we found was a clear-cut'Yes, according to Roseveltte. What's really interesting about Acrp30 is that we know that it is missing or lower in obese people.

He said the study suggests just small in creases have a major effect in decreasing glucose production in the liver and thereby improving insulin action in the liver. "This significant research points to the liver as the key sight of action by Acpr30," said Dr. Allen Cherrington, professor of physiology at Vanderbilt University Medical School in Nashville. "It could be one key in helping us find new ways to lower glucose profiles in type-2 diabetics and slow the development of disease."

Acrp30 is a very large protein and it can only be given by injection. "The future of this biological discovery is in identifying either the receptor for the protein, in other words how it is working in the liver, and then creating a smaller molecule that will mimic the effect of Acrp30 or perhaps finding a way to stimulate the secretion of Acrp30 within the fat cell," Roseveltte said. "Either of these strategies will be targets of companies trying to develop drugs from this kind of research."


'"/>




Related medicine news :

1. Lean Protein Could Be Key to Obesity Drugs
2. Evidence Links Protein Damage to Neurodegenerative diseases like Parkinsons and Alzheimers
3. Unravelling the secrets of ‘Huntingtin’ Protein - towards the treatment of ‘Huntingtons’ Disase
4. Unravelling the secrets of ‘Huntingtin’ Protein - towards the treatment of Huntingtins’ Disese
5. Protein in urine foresees heart disease
6. Levels Of Blood Proteins May Help Heart Disease Care
7. Protein signals need for heart surgery
8. Protein and fat improve memory
9. Clotting Protein plays a role in nerve repair
10. High Levels of Protein Linked to Brain Shrinkage
11. Protein can change worn muscle fibres
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/23/2017)... Portland, Oregon (PRWEB) , ... January 23, 2017 ... ... systems, announced today it has earned organic certification under the USDA National Organic ... the USDA Organic Certification process, we have established organic production and handling systems ...
(Date:1/23/2017)... ... 2017 , ... "ProRandom is a set of camera tools that allow video editors to integrate ... Pro X," said Christina Austin - CEO of Pixel Film Studios. , With ProRandom, ... video footage. ProRandom works by using a virtual camera to create the illusion of ...
(Date:1/23/2017)... ... January 23, 2017 , ... Old School Labs™, makers of ... Olympia Classic Physique bodybuilder Breon Ansley to its growing team of brand ambassadors. The ... in 2012 and in less than a year was able to turn professional, participating ...
(Date:1/23/2017)... , ... January 23, 2017 ... ... Foundation (OREF), in partnership with the American Society of Anesthesiologists® (ASA®), the ... (APSF), the American Academy of Orthopaedic Surgeons (AAOS) and the Cigna Foundation, ...
(Date:1/23/2017)... ... January 23, 2017 , ... ... general gynecological care and gynecological services for women of all ages. ... for a wide variety of reproductive services from routine health screenings to diagnosing ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... SAN DIEGO , 23 janvier 2017  ResMed ... Winter Haven , Floride) ont annoncé aujourd,hui qu,ils se ... les litiges existants entre les parties. BMC et 3B ... de paiements de droits à ResMed, et ResMed effectuera ... à 3B pour clore le litige de Floride entre ...
(Date:1/23/2017)... 2017  ResMed (NYSE: RMD ), BMC ... ( Winter Haven, Florida ) gaben heute ... Beilegung aller globalen Rechtsstreitigkeiten zwischen den Parteien geeinigt haben. ... bestehenden Produkte im Tausch gegen Lizenzgebühren an ResMed gestattet, ... um das in Florida anhängige ...
(Date:1/23/2017)... Spain , January 23, 2017 ... clinical-stage biopharmaceutical company focused on treatments for calcification ... been enrolled in the Phase IIb "CaLIPSO Study" ... treatment of cardiovascular calcification (CVC) in end-stage-renal-disease (ESRD) ... patients, in the last stage of chronic kidney ...
Breaking Medicine Technology: